Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 81767, 6 pages
http://dx.doi.org/10.1155/MI/2006/81767
Research Communication

Interleukin 6 and 8 Levels in Plasma and Fibroblast Cultures in Psoriasis

1Department of Dermatology and Venereology, Medical University of Łódź, 5 Krzemieniecka Street, Łódź 94-017, Poland
2Department of Clinical Immunology, Polish Mother’s Memorial Hospital-Research Institute, 93-338 Łódź, Poland
3Centre for Medical Biology, Polish Academy of Sciences, Łódź 93-232, Poland

Received 21 September 2005; Accepted 20 October 2005

Copyright © 2006 Anna Zalewska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B S Baker, A F Swain, H Valdimarsson, and L Fry, “T-cell subpopulations in the blood and skin of patients with psoriasis,” British Journal of Dermatology, vol. 110, no. 1, pp. 37–44, 1984. View at Publisher · View at Google Scholar
  2. C E Griffiths and J J Voorhees, “Immunological mechanisms involved in psoriasis,” Springer Seminars in Immunopathology, vol. 13, no. 3-4, pp. 441–454, 1992. View at Publisher · View at Google Scholar
  3. A Kapp, “The role of cytokines for the pathogenesis of psoriasis,” Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete, vol. 44, no. 4, pp. 201–207, 1993. View at Google Scholar
  4. M P Schon and W H Boehncke, “Psoriasis,” The New England Journal of Medicine, vol. 352, no. 18, pp. 1899–1912, 2005. View at Publisher · View at Google Scholar
  5. T J Smith, “Insights into the role of fibroblasts in human autoimmune diseases,” Clinical and Experimental Immunology, vol. 141, no. 3, pp. 388–397, 2005. View at Publisher · View at Google Scholar
  6. C D Buckley, D Pilling, J M Lord, A N Akbar, D Scheel-Toellner, and M Salmon, “Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation,” Trends in Immunology, vol. 22, no. 4, pp. 199–204, 2001. View at Publisher · View at Google Scholar
  7. E P Prens, K Benne, J van Damme et al., “Interleukin-1 and interleukin-6 in psoriasis,” The Journal of Investigative Dermatology, vol. 95, no. 6 suppl, pp. 121S–124S, 1990. View at Publisher · View at Google Scholar
  8. R Debets, J PJJ Hegmans, M Deleuran, S Hooft, R Benner, and E P Prens, “Expression of cytokines and their receptors by psoriatic fibroblast. I. Altered IL-6 synthesis,” Cytokine, vol. 8, no. 1, pp. 70–79, 1996. View at Publisher · View at Google Scholar
  9. E C Borden and P Chin, “Interleukin-6: a cytokine with potential diagnostic and therapeutic roles,” The Journal of Laboratory and Clinical Medicine, vol. 123, no. 6, pp. 824–829, 1994. View at Google Scholar
  10. A Castells-Rodellas, J V Castell, A Ramirez-Bosca, J F Nicolas, F Valcuende-Cavero, and J Thivolet, “Interleukin-6 in normal skin and psoriasis,” Acta Dermato-Venereologica, vol. 72, no. 3, pp. 165–168, 1992. View at Google Scholar
  11. J T Elder, C I Sartor, D K Boman, S Benrazavi, G J Fisher, and M R Pittelkow, “Interleukin-6 in psoriasis: expression and mitogenicity studies,” Archives of Dermatological Research, vol. 284, no. 6, pp. 324–332, 1992. View at Publisher · View at Google Scholar
  12. B J Nickoloff, G D Karabin, J NWN Barker et al., “Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis,” The American Journal of Pathology, vol. 138, no. 1, pp. 129–140, 1991. View at Google Scholar
  13. A J Gearing, N J Fincham, C R Bird et al., “Cytokines in skin lesions of psoriasis,” Cytokine, vol. 2, no. 1, pp. 68–75, 1990. View at Publisher · View at Google Scholar
  14. T Fredriksson and U Pettersson, “Severe psoriasis—oral therapy with a new retinoid,” Dermatologica, vol. 157, no. 4, pp. 238–244, 1978. View at Google Scholar
  15. J Schmitt and G Wozel, “The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis,” Dermatology, vol. 210, no. 3, pp. 194–199, 2005. View at Publisher · View at Google Scholar
  16. D Kemmett, J A Symons, G B Colver, and G W Duff, “Serum-soluble interleukin 2 receptor in psoriasis. Failure to reflect clinical improvement,” Acta Dermato-Venereologica, vol. 70, no. 3, pp. 264–266, 1990. View at Google Scholar
  17. C Bonifati and F Ameglio, “Cytokines in psoriasis,” International Journal of Dermatology, vol. 38, no. 4, pp. 241–251, 1999. View at Publisher · View at Google Scholar
  18. R E Lee, A A Gaspari, M T Lotze, A E Chang, and S A Rosenberg, “Interleukin 2 and psoriasis,” Archives of Dermatology, vol. 124, no. 12, pp. 1811–1815, 1988. View at Publisher · View at Google Scholar
  19. G Chodorowska, “Plasma concentrations of IFN-γ and TNF-α in psoriatic patients before and after local treatment with dithranol ointment,” Journal of the European Academy of Dermatology and Venereology: JEADV, vol. 10, no. 2, pp. 147–151, 1998. View at Google Scholar
  20. R S Smith, T J Smith, T M Blieden, and R P Phipps, “Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation,” The American Journal of Pathology, vol. 151, no. 2, pp. 317–322, 1997. View at Google Scholar
  21. A Zalewska, M Bowszyc-Dmochowska, B Dziankowska-Barkowiak, R Bratos, and A Sysa-Jedrzejowska, “Increased accumulation of fibroblasts in the dermis of psoriatic patients,” The Journal of Investigative Dermatology, vol. 115, p. 583, 2000. View at Google Scholar
  22. D Kovacs, M Falchi, G Cardinali et al., “Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis,” Experimental Dermatology, vol. 14, no. 2, pp. 130–137, 2005. View at Publisher · View at Google Scholar
  23. A Kapp, A Piskorski, and E Schopf, “Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis,” British Journal of Dermatology, vol. 119, no. 6, pp. 707–710, 1988. View at Publisher · View at Google Scholar
  24. A Oxholm, P Oxholm, B Staberg, and K Bendtzen, “Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment,” Acta Dermato-Venereologica, vol. 69, no. 3, pp. 195–199, 1989. View at Google Scholar
  25. M Carducci, A Mussi, C Bonifati, M Fazio, and F Ameglio, “sICAM-1, sIL-2R and beta 2-microglobulin serum levels in patients affected with psoriasis: relationship with disease severity,” Archives of Dermatological Research, vol. 286, no. 7, pp. 420–422, 1994. View at Publisher · View at Google Scholar
  26. U Mrowietz, H Jessat, A Schwarz, and T Schwarz, “Anthralin (dithranol) in vitro inhibits human monocytes to secrete IL-6, IL-8 and TNF-alpha, but not IL-1,” British Journal of Dermatology, vol. 136, no. 4, pp. 542–547, 1997. View at Publisher · View at Google Scholar
  27. R Betti, A Rosti, A Lodi et al., “Effect of UVB plus tar therapy on serum levels of interleukin-2 receptors in patients with psoriasis,” Clinical and Experimental Dermatology, vol. 16, no. 5, pp. 364–366, 1991. View at Publisher · View at Google Scholar
  28. A Mussi, C Bonifati, M Carducci et al., “Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis,” Journal of Biological Regulators & Homeostatic Agents, vol. 11, no. 3, pp. 115–118, 1997. View at Google Scholar
  29. F Ameglio, C Bonifati, M Pietravalle, and M Fazio, “Interleukin-6 and tumour necrosis factor levels decrease in the suction blister fluids of psoriatic patients during effective therapy,” Dermatology, vol. 189, no. 4, pp. 359–363, 1994. View at Google Scholar
  30. C Bonifati, M Carducci, P Cordiali Fei et al., “Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients—relationships with disease severity,” Clinical and Experimental Dermatology, vol. 19, no. 5, pp. 383–387, 1994. View at Publisher · View at Google Scholar
  31. C Bonifati, M Solmone, E Trento, M Pietravalle, M Fazio, and F Ameglio, “Serum interleukin-6 levels as an early marker of therapeutic response to UVB radiation and topical steroids in psoriatic patients,” International Journal of Clinical & Laboratory Research, vol. 24, no. 2, pp. 122–123, 1994. View at Google Scholar
  32. C Bonifati, M Carducci, A Mussi, L D'auria, and F Ameglio, “IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin,” Journal of Biological Regulators & Homeostatic Agents, vol. 11, no. 4, pp. 133–136, 1997. View at Google Scholar
  33. A Abanmi, F Al Harthi, R Al Agla, H A Khan, and M Tariq, “Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia,” International Journal of Dermatology, vol. 44, no. 1, pp. 82–83, 2005. View at Publisher · View at Google Scholar
  34. L Naldi, “A new era in the management of psoriasis? Promises and facts,” Dermatology, vol. 210, no. 3, pp. 179–181, 2005. View at Publisher · View at Google Scholar
  35. U Hettmannsperger, M Detmar, M Owsianowski, S Tenorio, H J Kammler, and C E Orfanos, “Cytokine-stimulated human dermal microvascular endothelial cells produce interleukin 6—inhibition by hydrocortisone, dexamethasone, and calcitriol,” The Journal of Investigative Dermatology, vol. 99, no. 5, pp. 531–536, 1992. View at Publisher · View at Google Scholar
  36. Y Ohta, I Katayama, T Funato et al., “In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions,” Archives of Dermatological Research, vol. 283, no. 6, pp. 351–356, 1991. View at Publisher · View at Google Scholar
  37. P Neuner, A Urbanski, F Trautinger et al., “Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis,” The Journal of Investigative Dermatology, vol. 97, no. 1, pp. 27–33, 1991. View at Publisher · View at Google Scholar
  38. Y Yoshinaga, M Higaki, S Terajima et al., “Detection of inflammatory cytokines in psoriatic skin,” Archives of Dermatological Research, vol. 287, no. 2, pp. 158–164, 1995. View at Publisher · View at Google Scholar
  39. D Biasi, A Carletto, P Caramaschi et al., “Neutrophil functions and IL-8 in psoriatic arthritis and in cutaneous psoriasis,” Inflammation, vol. 22, no. 5, pp. 533–543, 1998. View at Publisher · View at Google Scholar
  40. R M Grossman, J Krueger, D Yourish et al., “Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 16, pp. 6367–6371, 1989. View at Publisher · View at Google Scholar
  41. F Myokai, E Koyama, K Nishikawa, S Noji, Y Murayama, and S Taniguchi, “Aspects of interleukin-8 gene expression by gingival and dermal fibroblasts stimulated with interleukin-1beta or tumour necrosis factor alpha,” Journal of the International Academy of Periodontology, vol. 6, no. 1, pp. 21–28, 2004. View at Google Scholar
  42. C Johansen, E Flindt, K Kragballe et al., “Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin,” The Journal of Investigative Dermatology, vol. 124, no. 6, pp. 1284–1292, 2005. View at Publisher · View at Google Scholar
  43. C L Carroll, S R Feldman, F T Camacho, and R Balkrishnan, “Better medication adherence results in greater improvement in severity of psoriasis,” British Journal of Dermatology, vol. 151, no. 4, pp. 895–897, 2004. View at Publisher · View at Google Scholar
  44. S S Zaghloul and M J Goodfield, “Objective assessment of compliance with psoriasis treatment,” Archives of Dermatology, vol. 140, no. 4, pp. 408–414, 2004. View at Publisher · View at Google Scholar